Portman Square Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-95,838
Closed -$1.86M – 255
2024
Q3
$1.95M Buy
95,838
+18,867
+25% +$386K 0.07% 229
2024
Q2
$1.74M Buy
76,971
+30,000
+64% +$786K 0.06% 236
2024
Q1
$1.23M Buy
46,971
+35,444
+307% +$1.01M 0.03% 230
2023
Q4
$364K Sell
11,527
-37,753
-77% -$1.02M 0.01% 406
2023
Q3
$1.38M Buy
49,280
+41,405
+526% +$1.42M 0.03% 341
2023
Q2
$291K Buy
+7,875
New +$240K 0.01% 365

Other funds holding CC

Portman Square Capital's CC Position: Q4 2024 in Review

Portman Square Capital sold out of Chemours (CC) in Q4 2024, closing a stake of 95,838 shares — an estimated $1.86M sold.

Portman Square Capital first reported a position in CC in Q2 2023 and held it in 6 quarters. The position peaked at $1.95M in Q3 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • Portman Square Capital reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • Portman Square Capital sold 95,838 Chemours shares in Q4 2024, an estimated $1.86M.
  • Portman Square Capital first reported a position in Chemours in Q2 2023 and held it in 6 quarters.
  • Portman Square Capital's Chemours position peaked at $1.95M in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Portman Square Capital's 13F filing for Q4 2024, filed 16 Jan 2025.